First Mercantile Trust’s Bioverativ Inc. Common Stock BIVV Stock Holding History

First Mercantile Trust’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,700	Closed	-$92K	–	859
2017 Q4	$92K	Buy	+1,700	New	+$93K	0.02%	724
2017 Q3	–	Sell	-2,575	Closed	-$155K	–	849
2017 Q2	$155K	Buy	+2,575	New	+$147K	0.03%	625

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

First Mercantile Trust's BIVV Position: Q1 2018 in Review

First Mercantile Trust sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,700 shares — an estimated $92K sold.

First Mercantile Trust first reported a position in BIVV in Q2 2017 and held it in 2 quarters. The position peaked at $155K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

First Mercantile Trust reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
First Mercantile Trust sold 1,700 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $92K.
First Mercantile Trust first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 2 quarters.
First Mercantile Trust's Bioverativ Inc. Common Stock position peaked at $155K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on First Mercantile Trust's 13F filing for Q1 2018, filed 8 May 2018.